Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.
Journal: JCO precision oncology
Published: July 08, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 11, 2026
Emergency Department-to-Outpatient Oncology Transitions of Care Through a Cancer Diagnostics Program: Implementation and Feasibility.
Journal: Journal of the American College of Radiology : JACR
Published: September 28, 2025
Real-World Enfortumab Vedotin ± Pembrolizumab Treatment-Based Toxicities and Associations With Survival in Advanced Urothelial Carcinoma.
Journal: Clinical genitourinary cancer
Published: August 27, 2025
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification Schemes.
Journal: European urology
Published: February 27, 2025
Presence of an Artificial Intelligence-powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non-muscle-invasive Bladder Cancer.
Journal: European urology oncology
Published: November 18, 2024
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center Cohort.
Journal: The Journal of urology
Published: October 09, 2024
Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab Vedotin.
Journal: Clinical genitourinary cancer
Published: February 09, 2024
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer.
Journal: Cell reports. Medicine
Published: August 31, 2022
Extracellular Vesicle-Based Multianalyte Liquid Biopsy as a Diagnostic for Cancer.
Journal: Annual review of biomedical data science
Published: May 14, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study.
Journal: JTO clinical and research reports
Published: January 18, 2022
Last Updated: 09/26/2026